期刊文献+

CD4+CD25+调节性T细胞在系统性硬化病患者外周血的表达和意义 被引量:3

The expression and significance of CD4*CD25+ regulatory T cells in the peripheral blood of patients with systemic sclerosis
原文传递
导出
摘要 目的研究SSc患者外周血CD4+CD25+调节性T细胞的表型和功能及与纤维化病变的关系。方法用流式细胞术检测ssc患者及健康对照者外周血CD4+CD25+调节性T细胞叉头翼状螺旋转录因子(Foxp3)、CD127、T细胞毒性相关抗原(CTLA)-4、CD69所占比例,ELISA法检测血清TGF-β1、IL-10细胞因子水平,并分析调节性T细胞与患者胸部高分辨CT(HRCT)评分、修订的Rodnan皮肤硬化评分(MRSS)和疾病活动指标的相关性。采用t检验和Pearson相关分析法进行统计学分析。结果①与健康对照组比较,SSc患者外周血CD4+CD25+调节性T细胞比例增加(12.9±2.4与14.9±2.2,t=2.63,P=0.012),表面表达CD69+、CTLA-4+比例均降低。②与健康对照组比较,SSc患者外周血CD4+CD25+ Foxp3+细胞、CD4+CD25+CD127咖胞比例升高(分别为3.3±0.7与5.0±0.7,5.1±1.6与7.6±2.0,t=7.03,4.195;P〈0.01),但两者无明显相关性。③SSc患者血清TGF-β1水平较健康对照组降低[(86±29)ng/ml与(133±29)ng/ml,t=-5.026,P=0.000],IL-10水平差异则无统计学意义。④SSe患者外周血CD4+CD25+ Foxp3+、CD4+CD25+ CD127一调节性T细胞比例与胸部高分辨率CT(HRCT)评分呈正相关(分别为r=0.541,P=0.02;r=0.486,P=-0.041),与ESR、CRP无相关。CD4+CD25+Foxp3+细胞比例与MRSS正相关。结论SSc患者外周血CD4+CD25+调节性T细胞比例增加,免疫功能改变,不同表型CD4+CD25+Foxp3+,cD4+CD25+D127-细胞比例增高,与皮肤和肺纤维化病变正相关,相关的细胞因子TGF-β1减少,IL-10无明显改变。 Objective To study the phenotype and function of CD4 +CD25 + Treg cells in the peripheral blood of patients with systemic sclerosis (SSc) and their relationship with fibrosis. Methods The proportion of Foxp3, CD127, CTLA-4 and CD69 on CD4+CD25+ Treg cells in peripheral blood were detect by flow cytometry; the levels of TGF-[3, and IL-10 in serum were detect by enzyme-linked immunosorbent assay (ELISA) in patients with SSc. The correlation between Treg cells and the score of chest HRCT, MRSS, and disease activity was analyzed. T test and Pearson correlation analysis were used for statistical analysis. Results ① Compare to the control group, the proportion of CD4+CD25+ Treg cells in peripheral blood of SSc patients was increased significantly( 12.9±2.4 vs 14.9±2.2, t=2.63, P=0.012), and the expression of CD69+, CTLA-4+ on CD4+CD25+ Treg cells was decreased significantly (P〈0.01). ② Compare to the control group, the proportion of CIM+CD25+Foxp3+ cells and CD4+CD25+CD127- cells in peripheral blood of SSc patients was increased significantly (respectively, 3.3±0.7 vs 5.0+0.7, 5.1±1.6 vs 7.6:t:2.0, t=7.03, 4.195; P〈0.01 ), but no correlation between them was detected. ③ The level of TGF-β, in the serum of the SSc patients was lower than that of the control group(86±29 vs 133±29 ng/ml, t=-5.026, P=0.000). However, IL-IO had no significant difference between the two groups. ④ The proportion of CD4+CD25 +Foxp3 + cells and CD4+CD25 +CD127- cells in peripheral blood of SSc patients was positively correlated with the scores of chest HRCT (respectively, r=0.541, P=0.02; r=0.486, P=0.041), and no correlation was observed with ESR, CRP. In addition, CD4+CD25+Foxp3+ ceils were associated with MRSS. Conclusion The proportion of CD4+CD25 + Treg cells in the peripheral blood of SSc patients is increased, but they alters the immune function. The different phenotypes of Treg cells of CD4+CD25+Foxp3+ cells and CD4+CD25+CD127 ceils in peripheral blood of SSc patients are increased significantly, which changes along with skin and lung fibrosis. The associated cytokine TGF-β1 is reduced, and IL-10 is not significantly changed.
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2016年第4期235-239,共5页 Chinese Journal of Rheumatology
基金 广西自然科学基金(2013GXNSFAA019135) 广西壮族自治区教育厅高校科研项目(LX2014070) 广西壮族自治区卫生厅自筹经费科研课题(Z20140330)
关键词 硬皮病 系统性 转化生长因子13 CD4+CD25+调节性T细胞 叉头翼状螺旋转录因子 P3 CD127-细胞 Scleroderma, systemic Transforming growth factor beta CD4+CD25+ Treg cells Foxp3 CD127- ceils
  • 相关文献

参考文献2

二级参考文献25

  • 1Yang J,Chu Y,Yang X,et al.Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum,2009,60(5):1472-1483.
  • 2Valentini G,Della Rossa A,Bombardieri S,et al.European multicentre study to define disease activity criteria for systemic sclerosis.Ⅱ.Identification of disease activity variables and development of preliminary activity indexes.Ann Rheum Dis,2001,60(6):592-598.
  • 3Langrish CL,Chen Y,Blumenschein WM,et al.IL-23 drives a pathogenic T cell population that induces autoimmune inflammation.J Exp Med,2005,201 (2):233-240.
  • 4Korn T,Bettelli E,Oukka M,et al.IL-17 and Th17 Cells.Annu Rev Immunol,2009,27:485-517.
  • 5Harrington LE,Hatton RD,Mangan PR,et al.Interleukin 17-producing CD4 + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.Nat Immunol,2005,6(11):1123-1132.
  • 6Murata M,Fujimoto M,Matsushita T,et al.Clinical association of serum interleukin-17 levels in systemic sclerosis:is systemic sclerosis a Th17 disease? J Dermatol Sci,2008,50(3):240-242.
  • 7Curotto de Lafaille MA,Lafaille JJ.CD4+ regulatory T cells in autoimmunity and allergy.Curr Opin Immunol,2002,14 (6):771-778.
  • 8Slobodin G,Ahmad MS,Rosner I,et al.Regulatory T cells CD4+CD25brightFoxP3 + expansion in systemic sclerosis correlates with disease activity and severity.Cell Immunol,2010,261 (2):77-80.
  • 9Radstake TR,van Bon L,Broen J,et al.Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression.PLoS One,2009,4(6):e5981.
  • 10Prescott RJ,Freemont A J,Jones C J,Hoyland J,Fielding P.Sequential dermal microvascular and perivascular changes in the development of scleroderma.J Pathol 1992; 166:255-263.

共引文献10

同被引文献27

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部